Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 214 results found. Search for [ Glenmark Pharmaceuticals ]

Results 1 to 21 of 214
BusinessToday.In
May 30, 2019
Share Market Updates: Suzlon, Justdial, Infibeam, DCM Shriram and Adani Power were the top gainers on BSE, while on NSE, YES Bank, Bharti Airtel, NTPC, TCS and Bajaj Finance were the top gaining stocks.


PTI
May 29, 2019



PTI
May 27, 2019



E Kumar Sharma
New Delhi, May 16, 2019
Some of the generic companies, it points out, made unsolicited bids to customers of bigger players in cases where drug prices were high as a way to compete with a bigger generic player to grab a bigger share in the market. Interestingly, this exercise seems to have elements of attempts at trying to drive down prices to gain customers.


PTI
May 14, 2019
In separate clarifications to stock exchanges, the companies denied the accusations and stated they would defend themselves in the matter


PTI
May 14, 2019



Mudit Kapoor
May 14, 2019
Severe penalties could be levied on the Indian pharma companies varying from $13 million to $873 million; Glenmark could face the highest penalty, while Aurobindo the least.


BusinessToday.In
New Delhi, May 14, 2019
The lawsuit accuses Teva Pharmaceuticals USA Inc of orchestrating a sweeping scheme with 19 other companies to inflate drug prices, by more than 1,000% in some cases


PTI
May 14, 2019



BusinessToday.In
May 14, 2019
Markets Live: While Sensex is trading 263 points higher at 37,354, Nifty is up 83 points to 11,231.70. Sun Pharma, Vedanta and ICICI Bank were the top gainers on Sensex. Tata Steel, Bajaj Auto and Asian Paints were the top losers on Sensex.


PTI
New Delhi, May 14, 2019
Sun Pharma shares dived 9.39 per cent to close at Rs 396.85 on the BSE


PTI
May 13, 2019



PTI
May 7, 2019



PTI
May 7, 2019



PTI
May 3, 2019



PTI
May 3, 2019



E Kumar Sharma
April 30, 2019
Glenmark calls itself, \"the first company in the world to launch the novel SGLT2 inhibitor Remogliflozin and India, the first country to get access to this innovative drug


PTI
April 30, 2019



PTI
New Delhi, April 30, 2019
Glenmark said it will commercialise Remogliflozin in India under the brand names 'Remo' and 'Remozen'


PTI
April 30, 2019



PAGES 1 OF 11  12345